3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Brain Neoplasms
4
Neoplasms
2
Breast Neoplasms
2
Sarcoma
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Hodgkin Disease
1
Glioma
1
Glioblastoma
1
Fatigue
1
Cytokine Release Syndrome
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Astrocytoma
1
Interventions
Paclitaxel
7
Oxaliplatin
6
Vincristine
4
Radiotherapy
4
Leucovorin
4
Carboplatin
4
Amifostine
4
Taxes
3
Sodium Chloride
3
Procarbazine
3
Methotrexate
3
Fluorouracil
3
Cytarabine
3
xaliproden
2
glucarpidase
2
Rituximab
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Prednisolone
2
Magnesium Sulfate
2
Duloxetine Hydrochloride
2
Dexamethasone
2
Cyclophosphamide
2
Cisplatin
2
Calcium Gluconate
2
Acupuncture Therapy
2
neurotropin
1
motexafin gadolinium
1
haloperidol decanoate
1
glutamic acid diethyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neurotoxicity Syndromes
×
Neuropsychological Tests
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled